Back to all tools
Supio logo
PaidAPI

Supio Review, Pricing & Alternatives (2026)

AI casework for plaintiff firms handling personal injury and mass torts

Last updated: October 26, 2026

What is Supio?

Supio is a hosted legal AI platform for plaintiff-side personal injury and mass-tort firms. It combines document intelligence, intake, drafting, case economics, and agentic workflows, with APIs and CMS connectors for customer applications. Supio publishes no dollar prices. Its entry point is a custom Case Subscription or Unlimited Firm Access quote.

Supio website screenshot
Supio homepage, captured October 2026

Supio is a Seattle legal AI company focused on personal injury and mass tort plaintiff firms. It emerged from stealth in August 2024 with a $25 million Series A, then announced a $60 million Series B on April 30, 2025, bringing reported total funding to $91 million. Sapphire Ventures led the Series B, with Mayfield and Thomson Reuters Ventures participating. Supio is built for firms processing substantial case records and portfolios, rather than for general legal question answering. Its named workflows include chronologies, demand letters, case ledgers, litigation drafting, intake, and agentic case operations. The company describes specialized, purpose-built AI models and human expert verification, but does not name the foundation model vendors behind the service.

Supio organizes case preparation around document intelligence and structured outputs. Case Economics, Case Signals, and the Drafting Suite address different stages of reviewing records and producing work product. Teams can create chronologies, demand letters, case ledgers, and litigation drafts. Supio Intake conducts intake around the clock, scores leads, and writes structured case data to a case-management system. Supio Agent, launched in May 2026, plans and executes finished work with attorney oversight at case, portfolio, and firm levels. Connectors support integrations and two-way CMS synchronization, while a Westlaw Advantage connection was announced in April 2026. The practical design is a shared operating layer for case preparation, lead handling, and drafting, rather than a single document-generation utility.

Supio says its system uses specialized, purpose-built AI models with human expert verification. It does not identify the underlying foundation model vendors, so buyers cannot compare model families or published context limits. Named releases in the company’s materials include Supio Agent and Supio Intake in May 2026, the Westlaw Advantage connection in April 2026, and a first-half 2026 report describing 17 times ARR growth since stealth. Supio also claims SOC 2 Type II, HIPAA, PHIPA, and GDPR compliance, with data centers in the United States, United Kingdom, and Canada. The company says customer information remains under client control and is not used to train foundation models. Public descriptions identify a hosted cloud service, not a self-hosted product.

Supio publishes two commercial access options, but neither has a dollar price. Case Subscription targets larger firms seeking a predictable, lower per-case cost. Unlimited Firm Access offers unlimited cases, users, and pages at the lowest per-case cost. Both options are described as having unlimited usage, no platform fees, and no lock-in contracts. The company says a pilot may begin with a handful of cases, yet it does not publish trial terms, minimum volumes, overage rules, or detailed entitlements. API pricing, quotas, authentication details, and usage limits are also unpublished. The headline unlimited terms are clear, but a buyer still needs a firm-specific quote to calculate annual cost and assess operational boundaries.

The main buying risk is opacity around commercial and technical details. Supio does not publish dollar prices, named model vendors, API limits, retention schedules, or self-hosted deployment options. EvenUp is the closest specialist comparison, covering plaintiff-injury intake, treatment, demands, negotiation, discovery, and trial, with MedChrons combining AI and professional or nurse review. Filevine’s LOIS is broader case-management software that acts on matters, deadlines, documents, and appointments inside its system of record. Litify combines Salesforce-based practice management with agentic workflows and a Supio-powered damages assistant. Supio should be picked by plaintiff firms wanting dedicated case intelligence, intake, drafting, and portfolio automation, provided a custom quote and contract answer their integration and governance requirements.

Who is Supio best for?

  • Plaintiff firms managing personal injury case documents.
  • Mass tort teams handling high volume case portfolios.
  • Firms needing AI intake linked to case management systems.
  • Teams seeking custom API and CMS integrations.

Supio Pricing (2026)

Pricing model: Paid. All prices in USD.

PlanPriceWhat you get
Case SubscriptionCustomUnlimited usage, users, and pages are published. Exact price, minimum volume, and entitlements are not published.
Unlimited Firm AccessCustomUnlimited cases, usage, users, and pages are published. Exact quote, minimum volume, and other limits are not published.

Pros and Cons

Pros

  • Supio targets personal injury and mass tort workflows directly.
  • Both published access options include unlimited users and pages.
  • Supio Agent adds attorney supervised case and portfolio automation.
  • Developer APIs and CMS connectors support custom workflows.

Cons

  • Supio does not publish dollar prices for either access option.
  • The company does not name its underlying foundation model vendors.
  • Supio does not publish API quotas or retention schedules.

Who should look elsewhere?

  • Solo users seeking a public self serve price.
  • Teams requiring self hosted or on premises deployment.
  • Buyers needing named foundation models and published API quotas.

Technical Details

Open SourceNo
Self-HostedNo
API AccessYes

Frequently Asked Questions

How much does Supio cost?

Supio does not publish dollar prices. Its pricing page describes Case Subscription for larger firms seeking predictable per case costs and Unlimited Firm Access for unlimited cases, users, and pages. Both are custom commercial options with no published platform fees or lock in contracts. Exact quotes, minimum volumes, pilot terms, and overage rules are not publicly specified.

Does Supio have a free plan or trial?

Supio does not publish a free plan or self serve trial. Its pricing materials say a pilot may begin with a handful of cases, but they do not state whether the pilot is free, how long it lasts, or what limits apply. Prospective customers therefore need a firm specific commercial discussion before knowing the pilot cost and scope.

How does Supio compare with EvenUp?

Supio covers document intelligence, case economics, drafting, intake, CMS connections, and agentic work across plaintiff matters. EvenUp is a direct plaintiff injury alternative with workflows spanning intake, treatment, demands, negotiation, discovery, and trial, including MedChrons with professional or nurse review. Supio fits firms prioritizing a broader case operating layer, while EvenUp emphasizes specialized injury workflows and reviewed medical records.

Does Supio train foundation models on customer data?

Supio says client information never leaves the client’s control and never trains foundation models. The company also lists SOC 2 Type II, HIPAA, PHIPA, and GDPR claims, plus data centers in the United States, United Kingdom, and Canada. Supio does not publish a detailed retention or deletion schedule, so those operational terms should be reviewed in the customer agreement.

Can firms use Supio commercially, and does it offer an API?

Supio is sold as commercial firm access through Case Subscription or Unlimited Firm Access. The company says secure developer APIs are available to customers for proprietary applications, dashboards, custom reports, and workflows. Its connectors support integrations and two way CMS synchronization. Supio does not publish API documentation, authentication details, quotas, or separate API prices.